We next carried out siRNA knockdown of TOP1, as well as topoisomerase 2 (TOP2), to assess whether depletion of either topoisomerase mimics the antiviral effects of CPT or alters the compound’s efficacy in suppressing viral infection. The gene discussed is TOP2A; the disease is viral infectious disease.